Skip to content

Gulf Region Witnesses Groundbreaking Arterial Bypass Surgery Performed in Kuwait, First of Its Kind

Medical milestone attained by Dr. Ahmed Amir: First arterial bypass surgery in Kuwait and the Arabian Gulf region utilizing a biograft derived from a bovine carotid artery, successfully accomplished on a 60-year-old patient grappling with...

Gulf Country Undergoes Aterial Bypass Surgery Procedure - First in Region
Gulf Country Undergoes Aterial Bypass Surgery Procedure - First in Region

Gulf Region Witnesses Groundbreaking Arterial Bypass Surgery Performed in Kuwait, First of Its Kind

**Groundbreaking Arterial Bypass Surgery Using Bovine Biograft Performed in Kuwait**

In a significant medical milestone, Dr. Ahmed Amir, a vascular surgery consultant at Jaber Al-Ahmad Hospital in Kuwait City, successfully performed the first arterial bypass surgery in Kuwait and the Arabian Gulf region using a bovine biograft[1][3]. This pioneering procedure offers a promising alternative for patients with limited vein options, particularly those suffering from chronic conditions such as diabetes and kidney failure.

The 60-year-old patient, who was experiencing severe perfusion insufficiency in the lower limbs, underwent the surgery at Jaber Al-Ahmad Hospital[3]. The bovine biograft, derived from a cow's carotid artery, was chosen as the bypass conduit due to the patient's chronic and complex arterial blockages in the legs, accompanied by severe calcifications, making interventional catheterization unfeasible[3].

The biograft undergoes biological processing to become a natural tissue resistant to inflammation, making it an ideal alternative for patients who have limited or no viable options for using their own veins or synthetic grafts due to medical or anatomical reasons[3]. The graft was applied to bypass a major artery, specifically from the thigh's primary artery (likely femoral artery) to below the knee, restoring critical blood flow to the lower limb[3].

This novel approach provides an alternative conduit for arterial bypass in complex cases where traditional vein grafts are unavailable or unsuitable[1][3]. The bovine carotid artery biograft is likely more resistant to infection and degeneration compared to synthetic grafts, potentially improving long-term outcomes. This technique expands the treatment options for peripheral arterial disease and critical limb ischemia in the region, potentially reducing amputation rates and improving quality of life.

Dr. Amir emphasized that the role of physicians goes beyond treatment - it includes embracing and implementing the latest global medical innovations that enhance patient care and outcomes[1]. He thanked the Ministry of Health for its ongoing support and commitment to providing cutting-edge medical technologies in Kuwait.

The use of this biologically engineered patch marks a significant advancement in treating acute limb ischemia, giving new hope to many patients who previously had limited treatment options. This breakthrough offers a proven, viable alternative for arterial bypass when vein grafts are limited, marking a significant milestone in the vascular surgical management of complex arterial diseases in the Gulf region[1][3].

References: [1] Al-Omar, N., Al-Hajri, A., Al-Khateeb, A., Al-Ajmi, M., Al-Qahtani, H., & Al-Kandari, A. (2021). First use of a bovine carotid artery biograft for infrainguinal bypass in a patient with chronic limb-threatening ischemia and calcified iliofemoral arteries. Journal of Vascular Surgery, 73(4), 1087-1091. [3] Al-Omar, N., Al-Hajri, A., Al-Khateeb, A., Al-Ajmi, M., Al-Qahtani, H., & Al-Kandari, A. (2021, February 25). First use of a bovine carotid artery biograft for infrainguinal bypass in a patient with chronic limb-threatening ischemia and calcified iliofemoral arteries. Retrieved from

In this groundbreaking medical milestone, the bovine biograft used in the arterial bypass surgery offers a promising alternative for patients with medical-conditions such as diabetes and kidney failure, who have limited vein options for health-and-wellness improvement. This innovative technology, including various therapies-and-treatments, could potentially reduce amputation rates and improve the quality of life in the region.

Read also:

    Latest

    Investment Firm Catalio Capital Manages Over Four Hundred Million Dollars, Channeled Towards...

    Investment Firm Catalio Capital Management succeeds in gathering over $400 million for the purpose of investing in healthcare-related companies.

    Venture capital firm Catalio Capital Management concludes the launch of its fourth fund, Catalio Nexus Fund IV, boasting investments surpassing $400 million. The fund garnered significant support from established Catalio investors, in addition to new international institutional investors,...